Early- and advanced non-enzymatic glycation in diabetic vascular complications: The search for therapeutics

Casper G. Schalkwijk, Toshio Miyata

研究成果: Review article査読

69 被引用数 (Scopus)

抄録

Cardiovascular disease is a common complication of diabetes and the leading cause of death among people with diabetes. Because of the huge premature morbidity and mortality associated with diabetes, prevention of vascular complications is a key issue. Although the exact mechanism by which vascular damage occurs in diabetes in not fully understood, numerous studies support the hypothesis of a causal relationship of non-enzymatic glycation with vascular complications. In this review, data which point to an important role of Amadori-modified glycated proteins and advanced glycation endproducts in vascular disease are surveyed. Because of the potential role of early- and advanced non-enzymatic glycation in vascular complications, we also described recent developments of pharmacological inhibitors that inhibit the formation of these glycated products or the biological consequences of glycation and thereby retard the development of vascular complications in diabetes.

本文言語English
ページ(範囲)1193-1204
ページ数12
ジャーナルAmino Acids
42
4
DOI
出版ステータスPublished - 2012 4

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Organic Chemistry

フィンガープリント 「Early- and advanced non-enzymatic glycation in diabetic vascular complications: The search for therapeutics」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル